http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1821161-C

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_332cb20f6e6a250f83a839b08a7c07d6
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-00
filingDate 1988-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f281fe54c5ba991a9a5b689de0719c6
publicationDate 1993-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-1821161-C
titleOfInvention Method of curing cavernous forms of nephrophthisis
abstract Usage: medicine, phthisiotri, for the treatment of cavernous forms of kidney tuberculosis. The inventive cavity is opened, the contents of the cavity are aspirated, cryothermal treatment of the surface of the cavity is carried out, cryothermal treatment is carried out before aspiration, and after aspiration the surface of the capsule cavity is blown: with an oxygen-ozone mixture and exposed to microwave radiation with a power of 70-80 W, and cryotherapy conducted to minus 60-70 °; C and heating to plus 42-45 ° C, blowing with an oxygen-ozone mixture is carried out at an ozone concentration. 1.08-1.2 mg / l at a flow rate of 2-3 l / min. EFFECT: invention allows to shorten the treatment period due to ablation.
priorityDate 1988-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559478
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID71414593
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451439960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24823
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454290454

Total number of triples: 18.